Re: Safety and Treatment Patterns of Angiogenesis Inhibitors in Patients with Metastatic Renal Cell Carcinoma: Evidence from US Community Oncology Clinics

The Journal of Urology ◽

10.1016/j.juro.2012.11.127 ◽

2013 ◽

Vol 189 (3) ◽

pp. 842-842

Author(s):

David F. Penson

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Angiogenesis Inhibitors ◽

Treatment Patterns ◽

Community Oncology

Download Full-text

Safety and treatment patterns of angiogenesis inhibitors in patients with metastatic renal cell carcinoma: evidence from US community oncology clinics

Medical Oncology ◽

10.1007/s12032-011-9922-z ◽

2011 ◽

Vol 29 (2) ◽

pp. 786-794 ◽

Author(s):

Bruce A. Feinberg ◽

Pradeep Jolly ◽

Si-Tien Wang ◽

Barry Fortner ◽

Jeffrey Scott ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Angiogenesis Inhibitors ◽

Treatment Patterns ◽

Community Oncology

Download Full-text

PCN51 HEALTH CARE COSTS ASSOCIATED WITH ANGIOGENESIS INHIBITORS (AIS) AND MTOR INHIBITORS (MTORS) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) TREATED AT US COMMUNITY ONCOLOGY CLINICS

Value in Health ◽

10.1016/s1098-3015(10)72140-9 ◽

2010 ◽

Vol 13 (3) ◽

pp. A33 ◽

Author(s):

K Chen ◽

SP Sarda ◽

L Antràs ◽

S Whittemore ◽

A Luka ◽

...

Keyword(s):

Health Care ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Health Care Costs ◽

Metastatic Renal Cell Carcinoma ◽

Mtor Inhibitors ◽

Angiogenesis Inhibitors ◽

Community Oncology ◽

Download Full-text

Treatment (trx) of metastatic renal cell carcinoma (mRCC) with angiogenesis inhibitors (AIs): Safety and treatment patterns observed in Taiwanese patients.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e15146 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e15146-e15146

Author(s):

Y. Chang ◽

Y. Ou ◽

C. Huang ◽

P. Chiang ◽

C. Chuang ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Angiogenesis Inhibitors ◽

Treatment Patterns

Download Full-text

7143 Safety and treatment (trx) patterns of angiogenesis inhibitors (AIs) in patients (pts) with metastatic renal cell carcinoma (mRCC): evidence from US community oncology clinics

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71476-4 ◽

2009 ◽

Vol 7 (2) ◽

pp. 436 ◽

Author(s):

S. Wang ◽

J. Ivanova ◽

L. Antras ◽

E. Chang ◽

P. Ramamurthy ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Angiogenesis Inhibitors ◽

Community Oncology

Download Full-text

Treatment patterns in metastatic renal cell carcinoma: a retrospective review of medical records from US community oncology practices

Current Medical Research and Opinion ◽

10.1185/03007995.2014.938730 ◽

2014 ◽

Vol 30 (10) ◽

pp. 2041-2050 ◽

Author(s):

Eric Jonasch ◽

James E. Signorovitch ◽

Peggy L. Lin ◽

Zhimei Liu ◽

Ken Culver ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Retrospective Review ◽

Medical Records ◽

Treatment Patterns ◽

Community Oncology

Download Full-text

Axitinib in metastatic renal cell carcinoma: patient characteristics and treatment patterns in US community oncology centers

Future Oncology ◽

10.2217/fon-2016-0566 ◽

2017 ◽

Vol 13 (15) ◽

pp. 1323-1332 ◽

Author(s):

Thomas E Hutson ◽

Xiaolong Jiao ◽

Thomas Wilson ◽

Laura Cisar ◽

Elizabeth A MacLean

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Patient Characteristics ◽

Renal Cell Carcinoma Patient ◽

Treatment Patterns ◽

Carcinoma Patient ◽

Community Oncology

Download Full-text

PCN2 SAFETY AND TREATMENT PATTERNS OF ANGIOGENESIS INHIBITORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) IN THE UNITED KINGDOM: PRELIMINARY RESULTS OF AN ONGOING CHARTS REVIEW STUDY

Value in Health ◽

10.1016/j.jval.2011.02.860 ◽

2011 ◽

Vol 14 (3) ◽

pp. A154-A155

Author(s):

R. Hawkins ◽

J. Wagstaff ◽

P. Nathan ◽

S.P. Sarda ◽

F. Vekeman ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

United Kingdom ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Angiogenesis Inhibitors ◽

Treatment Patterns ◽

Preliminary Results ◽

The United Kingdom ◽

Download Full-text

PCN341 REAL-WORLD TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION (HRU) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)

Value in Health ◽

10.1016/j.jval.2020.04.1799 ◽

2020 ◽

Vol 23 ◽

pp. S84

Author(s):

A. Bhanegaonkar ◽

G. Gauthier ◽

R. Kim ◽

F. Vekeman ◽

K. Dea ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Resource Utilization ◽

Metastatic Renal Cell Carcinoma ◽

Healthcare Resource ◽

Healthcare Resource Utilization ◽

Treatment Patterns

Download Full-text

Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma

IJU Case Reports ◽

10.1002/iju5.12220 ◽

2020 ◽

Vol 3 (6) ◽

pp. 287-290 ◽

Author(s):

Hiroki Hagimoto ◽

Soki Kashima ◽

Kazuki Doi ◽

Shintaro Nakayama ◽

Takanori Sano ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Pathological Complete Response ◽

Angiogenesis Inhibitors ◽

Complete Response

Download Full-text

Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK

10.1186/s12885-020-07154-z ◽

2020 ◽

Vol 20 (1) ◽

Author(s):

Robert Hawkins ◽

Kate Fife ◽

Michael Hurst ◽

Meng Wang ◽

Niroshini Naicker ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Health Outcomes ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Treatment Patterns ◽

The Uk ◽

Systemic Therapies

Download Full-text